Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Lung Neoplasms and MTOR[original query] |
|---|
| Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Aug . Miyoshi Tomohiro, Umemura Shigeki, Matsumura Yuki, Mimaki Sachiyo, Tada Satoshi, Ishii Genichiro, Udagawa Hibiki, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Aokage Keiju, Hishida Tomoyuki, Yoshida Junji, Nagai Kanji, Goto Koichi, Tsuboi Masahiro, Tsuchihara Katsu |
| Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). Oncotarget 2016 Apr . Lim Sun Min, Kim Hye Ryun, Cho Eun Kyung, Min Young Joo, Ahn Jin Seok, Ahn Myung-Ju, Park Keunchil, Cho Byoung Chul, Lee Ji-Hyun, Jeong Hye Cheol, Kim Eun Kyung, Kim Joo-Ha |
| Clinical correlation of extensive-stage small-cell lung cancer genomics. Annals of oncology : official journal of the European Society for Medical Oncology 2016 Apr 27 (4): 642-7. Dowlati A, Lipka M B, McColl K, Dabir S, Behtaj M, Kresak A, Miron A, Yang M, Sharma N, Fu P, Wildey |
| Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 8 12 (12): 1766-1778. Zhong Jia, Li Lei, Wang Zhijie, Bai Hua, Gai Fei, Duan Jianchun, Zhao Jun, Zhuo Minglei, Wang Yuyan, Wang Shuhang, Zang Wanchun, Wu Meina, An Tongtong, Rao Guanhua, Zhu Guanshan, Wang J |
| MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes. BioMed research international 2017 2017 6501385. Jiang Wei, Zhang Wenjue, Wu Lihong, Liu Lipin, Men Yu, Wang Jingbo, Liang Jun, Hui Zhouguang, Zhou Zongmei, Bi Nan, Wang Luh |
| Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer. Oncotarget 2017 Sep 8 (37): 61777-61785. Kang Hyo Gyoung, Yoo Seung Soo, Choi Jin Eun, Hong Mi Jeong, Do Sook Kyung, Jin Cheng Cheng, Kim Soyoun, Lee Won Kee, Choi Sun Ha, Lee So Yeon, Kim Hyun Jung, Lee Shin Yup, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Seok Yangki, Lee Eungbae, Cho Sukki, Jheon Sanghoon, Park Jae Yo |
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121. Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia |
| Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis. Lung cancer (Amsterdam, Netherlands) 2018 12 126 182-188. Udagawa Hibiki, Umemura Shigeki, Murakami Isao, Mimaki Sachiyo, Makinoshima Hideki, Ishii Genichiro, Miyoshi Tomohiro, Kirita Keisuke, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Tsuchihara Katsuya, Goto Koic |
| Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases. Current cancer drug targets 2018 Oct . Song Yuanyuan, Liu Peng, Huang Yu, Guan Yanfang, Han Xiaohong, Shi Yuank |
| Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer 2018 Jan . Ross Jeffrey S, Fakih Marwan, Ali Siraj M, Elvin Julia A, Schrock Alexa B, Suh James, Vergilio Jo-Anne, Ramkissoon Shakti, Severson Eric, Daniel Sugganth, Fabrizio David, Frampton Garrett, Sun James, Miller Vincent A, Stephens Philip J, Gay Laurie |
| Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC. Journal of cancer research and clinical oncology 2019 Aug . Deng Li-Li, Gao Ge, Deng Hong-Bin, Wang Feng, Wang Zhi-Hui, Yang |
| Survival prediction of tuberous sclerosis complex gene variant in patients with advanced non-small-cell lung cancer treated with platinum doublet. Bioscience reports 2019 Mar . Ryu Jeong-Seon, Lim Jun Hyeok, Kim Hyun-Jung, Kim Min Jeong, Park Mi Hwa, Kim Jung S |
| Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study. Cancer science 2019 12 111 (2): 679-686. Lei Lei, Wang Wen-Xian, Zhu You-Cai, Li Jin-Luan, Fang Yong, Wang Hong, Zhuang Wu, Zhang Yin-Bin, Wang Li-Ping, Fang Mei-Yu, Xu Chun-Wei, Wang Xiao-Jia, Lv Tang-Feng, Song Yo |
| Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing. BioMed research international 2019 11 2019 6096350. Su Shan, Zou Jian-Jun, Zeng Yun-Yun, Cen Wen-Chang, Zhou Wei, Liu Yan, Su Duo-Hua, Zhang Xian-Lan, Huang Hui-Yi, Lei An, Huang Zhi-Hao, Jin Yun, Li Lei, Su Ning, Xie Ya-Lin, Zhao Zhen-Gang, Liu Jian-Xio |
| Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma. The oncologist 2019 Nov . Fang Wenfeng, Zhao Shen, Liang Ying, Yang Yunpeng, Yang Lin, Dong Xiaorong, Zhang Li, Tang Yong, Wang Shoufeng, Yang Yang, Ma Xiaoyan, Wang Minghui, Wang Wenjing, Zhao Songhui, Wang Kai, Gao Song, Zhang |
| Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer. Journal of cancer research and clinical oncology 2019 Oct . Xu Yiquan, Huang Yina, Weng Lihong, Zheng Jiankun, Huang Yi, Lin Ying, Zhao Yunan, Li Hongru, Chen Yushe |
| PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy. Translational lung cancer research 2020 9 9 (4): 1258-1267. Fang Wenfeng, Huang Yihua, Gu Weiguang, Gan Jiadi, Wang Wenjing, Zhang Shiyue, Wang Kai, Zhan Jianhua, Yang Yunpeng, Huang Yan, Zhao Hongyun, Zhang |
| Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non?small cell lung cancer. Oncology reports 2020 Mar . Hu Jing, Shang Yanhong, Shi Xiaoliang, Zhang Shuirong, Shi Junping, Yao Ming, Wang Aodi, Shou Tao, Shi Weiwei, Wang Kai, Liu Angen, Pan Xiaojie, Wang Yongj |
| Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma. The oncologist 2020 3 25 (3): e545-e554. Fang Wenfeng, Zhao Shen, Liang Ying, Yang Yunpeng, Yang Lin, Dong Xiaorong, Zhang Li, Tang Yong, Wang Shoufeng, Yang Yang, Ma Xiaoyan, Wang Minghui, Wang Wenjing, Zhao Songhui, Wang Kai, Gao Song, Zhang |
| Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
| Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations. Journal of Cancer 2021 12 (17): 5099-5105. Yang Jing, Wang Xiangyun, Lu Jingli, Chen Hui, Zhao Xiaochen, Gao Chan, Bai Yuezong, Zhang Qiwen, Fu Xiaomin, Zhang Xiaoji |
| The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer. World journal of oncology 2022 5 13 (2): 84-95. Zhu Dao Qi, Liu Ying, Yu Zhi Jian, Zhang Ru Hua, Li Ai Wu, Gong Feng Ying, Wang Wei, Xiao Wei, Fan Q |
| Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer. Thoracic cancer 2022 Oct . Choi Sun Ha, Do Sook Kyung, Lee Shin Yup, Choi Jin Eun, Kang Hyo-Gyoung, Hong Mi Jeong, Lee Jang Hyuck, Lee Won Kee, Jeong Ji Yun, Shin Kyung Min, Do Young Woo, Lee Eung Bae, Park Ji Eun, Lee Yong Hoon, Seo Hyewon, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
| Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing. Neoplasma 2022 Jan . Zhang Hui, Jiang Da, Jin Hui, Cui Yan-Zhi, Wei Su-Ju, Li Ying, Dong Qian, Zuo Jing, Tian Cai-Juan, Yan Fang, Wang Xiao-W |
| Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. Frontiers in immunology 2022 13 872470. Lawal Bashir, Wu Alexander T H, Huang Hsu-Sh |
| Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
| Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study. Clinical genitourinary cancer 2024 6 22 (5): 102123. Joaquim Bellmunt, Pablo Maroto, Teresa Bonfill, Federico Vazquez, Jose Luis Perez-Gracia, Nuria Juanpere, Anna Hernandez-Prat, Silvia Hernandez-Llodra, Ana Rovira, Oscar Juan, Alejo Rodriguez-Vi |
| Clinical significance of a prospective large genomic screening for small-cell lung cancer: the genetic classification and a biomarker driven phase II trial of gedatolisib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 10 . Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, Haruyasu Murakami, Haruko Daga, Ryo Toyozawa, Toshiyuki Kozuki, Jun Sakakibara-Konishi, Yuichiro Ohe, Masahiro Morise, Terufumi Kato, Masato Shingyoji, Satoshi Hara, Naoki Furuya, Shuhei Teranishi, Saori Takata, Shingo Miyamoto, Ichiro Nakachi, Masashi Wakabayashi, Shogo Nomura, Akihiro Sato, Genichiro Ishii, Katsuya Tsuchihara, Eri Sugiyama, Keisuke Kirita, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, Kaname Nosaki, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Go |
- Page last reviewed:Feb 1, 2024
- Content source: